ACI’s OTC Drugs Advanced Forum

NEW YORK - Aug. 19, 2015 - PRLog -- August 18, 2015: American Conference Institute (“ACI”) is pleased to announce that the 4th Annual Advanced Legal, Regulatory, and Compliance Forum on Over the Counter Drugs, taking place at the DoubleTree Suites by Hilton-Times Square in New York City on October 28-30, 2015 will feature a comprehensive analysis of the Balancing of Advertising and Brand Promotion without Running Afoul of FDA and FTC Guidance as well as a discussion on how to Avoid Regulatory Pitfalls in Umbrella Branding, Trademarks and Trade Names.

To see more details, visit: www.AmericanConference.com/OTCDrugs

Co-Chairs:

- Vincent S. Egolf, Senior Counsel, Perrigo Company

- Renuka Singh, Sr. Regulatory Counsel, RB

FDA:

- John Whyte, MD, MPH, Director, Professional Affairs and Stakeholder Engagement Food and Drug Administration-Center for Drug Evaluation and Research

FTC:

- Brian N. Lasky, Attorney, Northeast Region, United States Federal Trade Commission

NAD:

- Martin S. Zwerling, Associate Director, National Advertising Division, Advertising Self-Regulatory Council (ASRC)

Industry:

- P. LaMont Bryant, PhD, Sr. Director, Regulatory Affairs, McNeil Consumer Healthcare/J&J

- Vincent S. Egolf, Senior Counsel, Perrigo Company

- Diane E. Furman, Senior Patent Counsel, Novartis Consumer Health Inc.

- David Grob, Vice President, Regulatory Affairs, Chattem, Inc.

- Mark Brian Levine, Associate General Counsel, RB

- Kathryn A. Meisel, Assistant General Counsel, Johnson & Johnson

- Raquel R. Mura, PharmD, JD, Vice President and Head of Regulatory Affairs, Sanofi Global Consumer Healthcare

- Valerie Ramsey, DRSc, MS, RAC, Director of Global Regulatory Affairs C.B. Fleet Company, Inc.

- Renuka Singh, Sr. Regulatory Counsel, RB

- Elizabeth M. Zechenter, Ph.D., Esq. Assistant General Counsel, Legal Operations Consumer Healthcare, GlaxoSmithKline Consumer Healthcare

Law Firm:

- John C. Balzano, Of Counsel, Covington & Burling LLP

- Ann M. Begley, Partner, Morgan Lewis & Bockius, LLP

- Dickerson M. Downing, Principal, Law Offices of Dickerson M. Downing

- Debra S. Dunne, R.Ph., Esq., Partner, Shook, Hardy & Bacon L.L.P

- Jeffrey R. Gargano, Partner, McDermott Will & Emery LLP

- Heidi Gertner, Partner, Hogan Lovells, (former Senior Counsel for Drugs at the FDA’s Office of Chief Counsel)

- Diane C. McEnroe, Partner, Sidley Austin LLP

- Raqiyyah R. Pippins, Special Counsel, Kelley Drye & Warren LLP

- Frederick A. Stearns, Partner, Keller and Heckman LLP

- Riëtte van Laack, PhD, Esq., Director, Hyman, Phelps & McNamara PC

- Steven A. Zalesin, Partner, Patterson Belknap Webb & Tyler, LLP

Full information on the forum can be found at www.AmericanConference.com/OTCDrugs

# # #

A unique organization, American Conference Institute is devoted to providing the business intelligence that senior decision-makers need to respond to challenges both here in the US, and around the world.

Staffed by industry specialists, lawyers, and other professionals, American Conference Institute operates as a think tank, monitoring trends and developments in all major industry sectors, the law, and public policy, with a view to providing information on the leading edge.

Headquartered in New York and led by Leigh Gilmore, Senior Vice President, and Seth Kerker, Managing Director, American Conference Institute has grown to produce more than 150 events each year, attended by thousands of senior delegates from across the country.